Exosome Diagnostics Inc - Product Pipeline Analysis, 2017 Update

  • ID: 4372822
  • Company Profile
  • 40 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • ActivX Biosciences Inc
  • Biocell Laboratories Inc
  • DEYMED Diagnostic
  • Image Diagnostics Inc
  • MORE
Summary

Exosome Diagnostics Inc (Exosome Diagnostics) is a provider of diagnostic solutions. The company develops, designs, manufactures and markets biofluid-based molecular diagnostic tests and products for use in personalized medicine. It offers liquid biopsy tests kits, EXO50 kits, EXO60 kits and EXO70 kits. Exosome Diagnostics’ services comprise miRNA profiling, mRNA profiling, mutation detection, and custom assay development services. The company also offers disease detection, diagnosis, treatment and monitoring. Its technology is used in the treatment of brain cancer, prostate cancer, and Alzheimer's disease. Exosome Diagnostics is headquartered in Waltham, Massachusetts the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Exosome Diagnostics Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • ActivX Biosciences Inc
  • Biocell Laboratories Inc
  • DEYMED Diagnostic
  • Image Diagnostics Inc
  • MORE
  • Exosome Diagnostics Inc Company Overview
  • Exosome Diagnostics Inc Company Snapshot
  • Exosome Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Exosome Diagnostics Inc - Pipeline Analysis Overview
  • Exosome Diagnostics Inc - Key Facts
  • Exosome Diagnostics Inc - Major Products and Services
  • Exosome Diagnostics Inc Pipeline Products by Development Stage
  • Exosome Diagnostics Inc Ongoing Clinical Trials by Trial Status
  • Exosome Diagnostics Inc Pipeline Products Overview
  • Biofluid Nucleic Acid Kit - Alzheimer's Disease
  • Biofluid Nucleic Acid Kit - Alzheimer's Disease Product Overview
  • Biofluid Nucleic Acid Kit - Cardiovascular Disease
  • Biofluid Nucleic Acid Kit - Cardiovascular Disease Product Overview
  • Biofluid Nucleic Acid Kit - Chronic Kidney Disease
  • Biofluid Nucleic Acid Kit - Chronic Kidney Disease Product Overview
  • Biofluid Nucleic Acid Kit - Parkinson's Disease
  • Biofluid Nucleic Acid Kit - Parkinson's Disease Product Overview
  • Biofluid-Based Molecular Diagnostic Test - Brain Cancer
  • Biofluid-Based Molecular Diagnostic Test - Brain Cancer Product Overview
  • Diagnostic Test - Neurodegenerative Diseases
  • Diagnostic Test - Neurodegenerative Diseases Product Overview
  • EXO1000
  • EXO1000 Product Overview
  • ExoDx Lung(EGFR)
  • ExoDx Lung(EGFR) Product Overview
  • ExoDx Lung(T790M)
  • ExoDx Lung(T790M) Product Overview
  • ExoDx Prostate(IntelliScore) - IVD Version
  • ExoDx Prostate(IntelliScore) - IVD Version Product Overview
  • ExoDx Prostate(IntelliScore) - IVD Version Clinical Trial
  • ExoDx Solid Tumor
  • ExoDx Solid Tumor Product Overview
  • Next-Generation Solid Tumor Mutation Panel
  • Next-Generation Solid Tumor Mutation Panel Product Overview
  • Shahky
  • Shahky Product Overview
  • Exosome Diagnostics Inc - Key Competitors
  • Exosome Diagnostics Inc - Key Employees
  • Exosome Diagnostics Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Recent Developments
  • Exosome Diagnostics Inc, Recent Developments
  • Jun 22, 2017: Exosome Diagnostics Presents Breakthrough Liquid Biopsy Technologies at BIO International Convention
  • May 31, 2017: Exosome Diagnostics Will Demonstrate the “Shahky” Point of Care Protein Detection Instrument at American Society for Clinical Oncology
  • Apr 26, 2017: American Medical Association Grants Exosome Diagnostics a CPT PLA Specific to Its ExoDx Prostate(IntelliScore) Test
  • Feb 03, 2017: Exosome Diagnostics Announces Early Access Program for “Shahky” - Exosome Protein Interrogation Instrument
  • Jan 18, 2017: Exosome Diagnostics Obtains ISO 15189 for Its Munich Laboratory
  • Jan 04, 2017: Exosome Diagnostics Runs World's First Point of Care Liquid Biopsy Instrument Within Leading Boston Hospital
  • Dec 21, 2016: Exosome Diagnostics Presented the Highest Sensitivity Liquid Biopsy Test for Lung Cancer
  • Dec 08, 2016: Exosome Diagnostics Announces the First Instrument for Point of Care Liquid Biopsy
  • Nov 10, 2016: Exosome Diagnostics Unveils Novel Platform for Detection of Clinically Relevant Biomarkers
  • Sep 13, 2016: Exosome Diagnostics Appoints Elizabeth Cormier-May as Head of Commercial Diagnostics
  • Appendix
  • Methodology
  • About
  • Contact
  • Disclaimer
List of Tables
  • Exosome Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Exosome Diagnostics Inc Pipeline Products by Equipment Type
  • Exosome Diagnostics Inc Pipeline Products by Indication
  • Exosome Diagnostics Inc Ongoing Clinical Trials by Trial Status
  • Exosome Diagnostics Inc, Key Facts
  • Exosome Diagnostics Inc, Major Products and Services
  • Exosome Diagnostics Inc Number of Pipeline Products by Development Stage
  • Exosome Diagnostics Inc Pipeline Products Summary by Development Stage
  • Exosome Diagnostics Inc Ongoing Clinical Trials by Trial Status
  • Exosome Diagnostics Inc Ongoing Clinical Trials Summary
  • Biofluid Nucleic Acid Kit - Alzheimer's Disease - Product Status
  • Biofluid Nucleic Acid Kit - Alzheimer's Disease - Product Description
  • Biofluid Nucleic Acid Kit - Cardiovascular Disease - Product Status
  • Biofluid Nucleic Acid Kit - Cardiovascular Disease - Product Description
  • Biofluid Nucleic Acid Kit - Chronic Kidney Disease - Product Status
  • Biofluid Nucleic Acid Kit - Chronic Kidney Disease - Product Description
  • Biofluid Nucleic Acid Kit - Parkinson's Disease - Product Status
  • Biofluid Nucleic Acid Kit - Parkinson's Disease - Product Description
  • Biofluid-Based Molecular Diagnostic Test - Brain Cancer - Product Status
  • Biofluid-Based Molecular Diagnostic Test - Brain Cancer - Product Description
  • Diagnostic Test - Neurodegenerative Diseases - Product Status
  • Diagnostic Test - Neurodegenerative Diseases - Product Description
  • EXO1000 - Product Status
  • EXO1000 - Product Description
  • ExoDx Lung(EGFR) - Product Status
  • ExoDx Lung(EGFR) - Product Description
  • ExoDx Lung(T790M) - Product Status
  • ExoDx Lung(T790M) - Product Description
  • ExoDx Prostate(IntelliScore) - IVD Version - Product Status
  • ExoDx Prostate(IntelliScore) - IVD Version - Product Description
  • ExoDx Prostate(IntelliScore) - IVD Version - Clinical Evaluation of the 'ExoDx Prostate IntelliScore' in Men Presenting for Initial Biopsy; Additional Confirmation Study including Impact on Decision-making and Health Economics
  • ExoDx Solid Tumor - Product Status
  • ExoDx Solid Tumor - Product Description
  • Next-Generation Solid Tumor Mutation Panel - Product Status
  • Next-Generation Solid Tumor Mutation Panel - Product Description
  • Shahky - Product Status
  • Shahky - Product Description
  • Exosome Diagnostics Inc, Key Employees
  • Exosome Diagnostics Inc, Subsidiaries
  • Glossary
List of Figures
  • Exosome Diagnostics Inc Pipeline Products by Equipment Type
  • Exosome Diagnostics Inc Pipeline Products by Development Stage
  • Exosome Diagnostics Inc Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Image Diagnostics Inc
  • DEYMED Diagnostic
  • Biocell Laboratories Inc
  • ActivX Biosciences Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll